Miyoko Saito Selected Research

miglitol (Glyset)

3/2021	S100 Genes are Highly Expressed in Peripheral Leukocytes of Type 2 Diabetes Mellitus Patients Treated with Dietary Therapy.
12/2016	Add-on therapy with anagliptin in Japanese patients with type-2 diabetes mellitus treated with metformin and miglitol can maintain higher concentrations of biologically active GLP-1/total GIP and a lower concentration of leptin.
9/2014	Switching α-glucosidase inhibitors to miglitol reduced glucose fluctuations and circulating cardiovascular disease risk factors in type 2 diabetic Japanese patients.
6/2014	Cotreatment with the α-glucosidase inhibitor miglitol and DPP-4 inhibitor sitagliptin improves glycemic control and reduces the expressions of CVD risk factors in type 2 diabetic Japanese patients.
12/2010	The α-glucosidase inhibitor miglitol decreases glucose fluctuations and inflammatory cytokine gene expression in peripheral leukocytes of Japanese patients with type 2 diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miyoko Saito Research Topics

Disease

12	Type 2 Diabetes Mellitus (MODY) 03/2021 - 12/2010
6	Hyperglycemia 03/2021 - 01/2014
3	Albuminuria 11/2020 - 02/2016
3	Hypoglycemia (Reactive Hypoglycemia) 12/2017 - 12/2010
2	Drug Resistant Epilepsy 01/2021 - 10/2002
2	Epilepsy (Aura) 01/2020 - 10/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2014 - 06/2014
1	Body Weight (Weight, Body) 11/2020
1	Chronic Renal Insufficiency 11/2020
1	Seizures (Absence Seizure) 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Fibrosis (Cirrhosis) 01/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Insulin Resistance 03/2018
1	Lafora Disease 01/2018
1	Weight Gain 12/2017
1	Diabetes Mellitus 12/2016
1	Obesity 12/2016
1	Atherosclerosis 06/2015
1	Polyneuropathies (Polyneuropathy) 09/2014
1	Hypothyroidism 09/2014
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2014
1	Cataract (Cataracts) 01/2012
1	Polymyositis 11/2010
1	Myositis (Idiopathic Inflammatory Myopathies) 11/2010
1	Dog Diseases (Disease, Canine) 11/2010
1	Heart Arrest (Cardiac Arrest) 10/2002
1	Apnea 10/2002
1	Seroma 10/2002
1	Horner Syndrome (Horner's Syndrome) 10/2002
1	Bradycardia 10/2002
1	Muscle Cramp (Cramp) 09/2002
1	Blastomycosis 01/2002

Drug/Important Bio-Agent (IBA)

7	GlucosidasesIBA 03/2021 - 12/2010
7	Glucose (Dextrose)FDA LinkGeneric 12/2019 - 12/2010
5	miglitol (Glyset)FDA Link 03/2021 - 12/2010
3	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 12/2016
3	Acarbose FDA LinkGeneric 09/2014 - 12/2010
2	Liraglutide FDA Link 11/2020 - 01/2014
2	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 01/2020 - 06/2014
2	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020 - 12/2016
2	LipidsIBA 03/2018 - 06/2015
2	voglibose (Basen)IBA 09/2014 - 12/2010
2	Insulin (Novolin)FDA Link 09/2014 - 12/2010
2	Sitagliptin Phosphate (Januvia)FDA Link 07/2014 - 06/2014
1	Messenger RNA (mRNA)IBA 03/2021
1	CreatinineIBA 11/2020
1	MedetomidineIBA 01/2020
1	Peptides (Polypeptides)IBA 12/2019
1	Glucagon (Glukagon)FDA Link 12/2019
1	CanagliflozinIBA 12/2019
1	Collagen Type IV (Type IV Collagen)IBA 01/2019
1	Serum AlbuminIBA 01/2019
1	Sodium-Glucose Transport ProteinsIBA 01/2019
1	Ferritins (Ferritin)IBA 01/2019
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2019
1	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 01/2019
1	potassium bromideIBA 10/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2017
1	VildagliptinIBA 12/2017
1	Alanine Transaminase (SGPT)IBA 01/2017
1	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2016
1	anagliptinIBA 12/2016
1	LeptinIBA 12/2016
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 02/2016
1	Plasminogen Activators (Plasminogen Activator)IBA 09/2014
1	ChemokinesIBA 09/2014
1	Monocyte Chemoattractant ProteinsIBA 09/2014
1	Fatty Acid-Binding ProteinsIBA 09/2014
1	Thyroxine (Levothyroxine)FDA LinkGeneric 09/2014
1	mitiglinideIBA 07/2014
1	Blood Glucose (Blood Sugar)IBA 07/2014
1	C-Reactive ProteinIBA 12/2010
1	CholesterolIBA 12/2010
1	Hemoglobin AIBA 12/2010
1	Triglycerides (Triacylglycerol)IBA 12/2010
1	CytokinesIBA 12/2010
1	AutoantibodiesIBA 11/2010
1	Prednisone (Sone)FDA LinkGeneric 09/2002
1	fludrocortisone acetate FDA LinkGeneric 09/2002

Therapy/Procedure

7	Therapeutics 03/2021 - 06/2014
4	Glycemic Control 12/2017 - 06/2014
2	Vagus Nerve Stimulation 01/2021 - 10/2002
2	Aftercare (After-Treatment) 11/2020 - 01/2002
1	Drug Therapy (Chemotherapy) 03/2021
1	Renal Dialysis (Hemodialysis) 01/2014
1	Capsulorhexis 01/2012
1	Phacoemulsification 01/2012
1	Cataract Extraction 01/2012
1	Sutures (Suture) 10/2002